Depression and Generalized Anxiety Disorder: Managed Care Considerations

home / publications / supplement / 2001-09-vol7-n11suppl

Participating Faculty

September 1st 2001

ArticleSUPPLEMENT CONTENT

Michael E. Thase, MD

September 1st 2001

ArticleSUPPLEMENT CONTENT

Current Perspectives on the Diagnosis and Treatment of Major Depressive Disorder

Andrew A. Nierenberg, MD

September 1st 2001

ArticleSUPPLEMENT CONTENT

Recent Perspectives on the Diagnosis and Treatment of Generalized Anxiety Disorder

Philip T. Ninan, MD

September 1st 2001

ArticleSUPPLEMENT CONTENT

The Clinical, Psychosocial, and Pharmacoeconomic Ramifications of Remission

Michael E. Thase, MD

September 1st 2001

ArticleSUPPLEMENT CONTENT

The Pharmacoeconomics of Venlafaxine in Depression

Thomas J. Morrow, MD

September 1st 2001

ArticleSUPPLEMENT CONTENT

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions